跳至主要内容
临床试验/EUCTR2009-015779-28-GB
EUCTR2009-015779-28-GB进行中(未招募)1 期

A single-centre randomised controlled trial of propofol cardioplegia on blood and myocardial biomarkers of stress and injury in patients having isolated coronary artery bypass grafting (CABG) or aortic valve replacement (AVR) using cardiopulmonary bypass (CPB) - Propofol cardioplegia for Myocardial Protection Trial: ProMPT

niversity Hospitals Bristol NHS Foundation Trust0 个研究点目标入组 101 人开始时间: 2010年6月28日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
101

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Participants may enter the study if ALL of the following apply: • Male or female • Age =18 to =80 years • Having elective or urgent CABG or AVR with CPB at the BHI • Able to give full informed consent for the study
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients may not enter the study if ANY of the following apply: • Previous cardiac surgery • Combined CABG and valve replacement • Emergency or salvage operation • Chronic renal failure requiring dialysis • Current congestive heart failure • Left ventricular ejection fraction <30% (i.e. Poor LV Function) • Allergy to peanuts, eggs, egg products, soybeans or soy products • Already participating in another clinical (interventional) study

研究者

发起方
niversity Hospitals Bristol NHS Foundation Trust

相似试验